GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 74.34
-1.77 (-2.33%)
At close: Jul 11, 2025
GKB Ophthalmics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,090 | 882.54 | 754.75 | 709.38 | 568.78 | Upgrade |
| 1,090 | 882.54 | 754.75 | 709.38 | 568.78 | Upgrade | |
Revenue Growth (YoY) | 23.49% | 16.93% | 6.40% | 24.72% | -2.83% | Upgrade |
Cost of Revenue | 734.46 | 603.45 | 482.01 | 453.76 | 374.19 | Upgrade |
Gross Profit | 355.42 | 279.09 | 272.73 | 255.62 | 194.6 | Upgrade |
Selling, General & Admin | 172.57 | 162.23 | 132.94 | 111.53 | 80.25 | Upgrade |
Other Operating Expenses | 210.67 | 111.07 | 102.94 | 94.55 | 92.09 | Upgrade |
Operating Expenses | 414.11 | 302.29 | 264.17 | 232.76 | 203.77 | Upgrade |
Operating Income | -58.7 | -23.2 | 8.56 | 22.85 | -9.18 | Upgrade |
Interest Expense | -23.71 | -13.85 | -12.95 | -11.14 | -11.44 | Upgrade |
Interest & Investment Income | - | 8.89 | 6.02 | 5.12 | 2.28 | Upgrade |
Earnings From Equity Investments | 1.83 | -0.59 | 0.33 | 0.91 | 6.23 | Upgrade |
Currency Exchange Gain (Loss) | - | 0.16 | 1.27 | 2 | - | Upgrade |
Other Non Operating Income (Expenses) | 13.31 | -1.21 | -2.42 | -1.85 | -7.38 | Upgrade |
EBT Excluding Unusual Items | -67.26 | -29.79 | 0.81 | 17.9 | -19.5 | Upgrade |
Gain (Loss) on Sale of Investments | - | 0 | - | 0.07 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.45 | 0.57 | -0.42 | -2.92 | Upgrade |
Asset Writedown | - | - | - | - | -7.21 | Upgrade |
Other Unusual Items | - | 1.59 | 0 | 0.06 | 20.2 | Upgrade |
Pretax Income | -67.26 | -27.76 | 1.39 | 19.46 | -9.29 | Upgrade |
Income Tax Expense | 3.53 | 2.06 | 0.23 | 0.02 | -1.8 | Upgrade |
Earnings From Continuing Operations | -70.79 | -29.82 | 1.16 | 19.44 | -7.48 | Upgrade |
Minority Interest in Earnings | 0.34 | 1.72 | -2.84 | -6.7 | -1.59 | Upgrade |
Net Income | -70.45 | -28.11 | -1.67 | 12.74 | -9.08 | Upgrade |
Net Income to Common | -70.45 | -28.11 | -1.67 | 12.74 | -9.08 | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Change (YoY) | -0.04% | - | - | 0.01% | - | Upgrade |
EPS (Basic) | -13.98 | -5.58 | -0.33 | 2.53 | -1.80 | Upgrade |
EPS (Diluted) | -13.98 | -5.58 | -0.33 | 2.53 | -1.80 | Upgrade |
Free Cash Flow | -55.77 | 21.44 | -39.87 | 3.11 | 5.23 | Upgrade |
Free Cash Flow Per Share | -11.07 | 4.25 | -7.91 | 0.62 | 1.04 | Upgrade |
Gross Margin | 32.61% | 31.62% | 36.14% | 36.03% | 34.21% | Upgrade |
Operating Margin | -5.38% | -2.63% | 1.13% | 3.22% | -1.61% | Upgrade |
Profit Margin | -6.46% | -3.19% | -0.22% | 1.80% | -1.60% | Upgrade |
Free Cash Flow Margin | -5.12% | 2.43% | -5.28% | 0.44% | 0.92% | Upgrade |
EBITDA | -27.83 | 5.78 | 36.83 | 49.52 | 22.22 | Upgrade |
EBITDA Margin | -2.55% | 0.66% | 4.88% | 6.98% | 3.91% | Upgrade |
D&A For EBITDA | 30.87 | 28.98 | 28.27 | 26.66 | 31.4 | Upgrade |
EBIT | -58.7 | -23.2 | 8.56 | 22.85 | -9.18 | Upgrade |
EBIT Margin | -5.38% | -2.63% | 1.13% | 3.22% | -1.61% | Upgrade |
Effective Tax Rate | - | - | 16.57% | 0.12% | - | Upgrade |
Revenue as Reported | 1,103 | 897.6 | 763.98 | 720.92 | 593.05 | Upgrade |
Advertising Expenses | - | 4.65 | 2.68 | 1.32 | 0.71 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.